DIATRIZOATE SODIUM

Search structure


Trade Names:	HYPAQUE HYPAQUE SODIUM 20% MD-50 UROVIST SODIUM 300
Synonyms:	Diatrizoate sodium Diatrizoic acid sodium salt Hypaque Hypaque Sodium Hypaque sodium 20% Md-50 Meglumine sodium amidotrizoate injection Natrii amidotrizoas NSC-61815 Sodium amidotrizoate Sodium diatrizoate Triombrine Urographing 370 Urovist sodium Urovist sodium 300
Status:	Approved (1954)
Entry Type:	Small molecule
Molecule Category:	Salt
UNII:	V5403H8VG7
Parent Compound:

Structure


InChI Key	ZEYOIOAKZLALAP-UHFFFAOYSA-M
Smile	CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)[O-])c1I.[Na+]
InChI	InChI=1S/C11H9I3N2O4.Na/c1-3(17)15-9-6(12)5(11(19)20)7(13)10(8(9)14)16-4(2)18;/h1-2H3,(H,15,17)(H,16,18)(H,19,20);/q;+1/p-1

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C11H8I3N2NaO4
Molecular Weight	635.9
AlogP	3.12
Hydrogen Bond Acceptor	3.0
Hydrogen Bond Donor	3.0
Number of Rotational Bond	3.0
Polar Surface Area	95.5
Molecular species	ACID
Aromatic Rings	1.0
Heavy Atoms	20.0

Pharmacology

Action	Mechanism of Action	Reference
None	Diagnostic agent	DailyMed

Indications

Mesh Heading	Maximum Phase	Mesh ID	Reference
Ileus	2	D045823	ClinicalTrials

Related Entries

UNKNOWN

Mixture

Adverse Reactions

SOC By Demographic Distribution

System Organ Classification (SOC)

	Relative Frequency (%)
Nervous system disorders	38.46
Injury, poisoning and procedural complications	10.26
General disorders and administration site conditions	8.97
Immune system disorders	7.69
Metabolism and nutrition disorders	5.13
Musculoskeletal and connective tissue disorders	5.13
Psychiatric disorders	5.13
Skin and subcutaneous tissue disorders	5.13
Vascular disorders	5.13

Cross References

Resources	Reference
ChEBI	53692
ChEMBL	CHEMBL1200581
EPA CompTox	DTXSID7022912
FDA SRS	V5403H8VG7
PubChem	23672589
SureChEMBL	SCHEMBL37116

CONTENTS